IME-META 7TH ADVANCED TRAINING AND CONFERENCE ON HEALTH ECONOMICS Is the crisis an opportunity or a curse? BEST WESTERN HOTEL HUNGARIA (1074 BUDAPEST, RÁKÓCZI ÚT 90. CONFERENCE FLOOR) 19-20.JUNE 2013 DRAFT PROGRAMME At the conference physicians can earn credit points. 19TH JUNE 2013 (WEDNESDAY) 8 00 8 45 Registration 8 45 9 15 Opening: Dr. Tótth, Árpád, Chairman of META, member of the IME Editorial Board Prof. György Kozmann D.Sc., editor in chief, IME 9 15 11 45 SECTION I. PLENARY SESSION MODERATOR: Dr. Dózsa, Csaba, META, IME Dr. Pásztélyi, Zsolt, IME 9 15 9 35 Dr. Tótth Árpád, Chairman of META Is the crisis an opportunity or a curse? 9 35 10 05 Dr. Kovács, Árpád, chairman of Hungary s Fiscal Council Macroeconomic report - The state of healthcare from a macroeconomic aspect 10 05 10 25 Dr. Keserű, György Miklós, Director General of the Research Centre for Natural Sciences of the Hungarian Academy of Sciences The challanges of drug research and development at the beginning of the 21st century 10 25 10 45 Dr. Molnár, Mária Judit, scientific vice-rector, Semmelweis University Personalized medicine 10 45 11 05 Dr. Jakab, Zoltán, chairman of AIPM The sustainability of innovative pharmaceutical industry in Hungary 11 05 11 45 Discussion 11 45 12 30 Poster presentation 12 30 13 30 Lunch 13 30 15 00 SECTION II. HEALTH POLICY I MODERATOR: Dr. Sinkó, Eszter, SE EMK, head of the Management and Health- Economics department of the Professional Association, IME Dr. Pásztélyi, Zsolt, IME 13 30 13 45 Cs. Horváth, Zoltán, University of Pécs The opportunity of establishing an integrated social care and healthcare system 13 45 14 00 Dr. Kövi, Rita, ELTE Faculty of Social Sciences
Levels of progressivity and capacity 14 00 14 15 Joó, Tamás, Vokó, Zoltán, Solymosy, József B., Vitrai, J, Balku, E, Martos, É, Bakacs, M. National Institute for Health Development Effects of the public health product tax - The importance of innovative leveraging techniques in times when there is a shortage of funds 14 15 14 30 Dr. Endrei, Dóra, Dr. Decsi Tamás, Dr. Bódis József, Zemplényi Antal, Dr. Ágoston István, Molics Bálint, Dr. Boncz Imre, University of Pécs Studying the subsidizing of active inpatient care of 2009-2012 14 30 14 45 Dr. Christian Boehler, Zoltan Kalo, Syreon Research Centre A new spectre is haunting Europe! International price referencing and its impact on lower income European economies 14 45 15 00 Discussion 15 00 17 15 INTERNATIONAL SESSION III. PERSONALIZED MEDICINES AND ORPHAN DRUGS MODERATOR: Dr. Kaló, Zoltán, META, IME 15 00 15 20 Pharm Dr. Dominik Tomek, MPH, PhD president of ISPOR Slovakia Chapter View of patients 15 20 15 40 Dr. Tomasz Bochenek, Institute of Public Health, Jagiellonian University, Krakow, Poland Public health view 15 40 16 00 Vladimir Zah PhD, ACIM, CPIAPD / Past-President ISPOR Serbian Chapter, Serbia View of ISPOR, including the SIG initiative 16 00 16 20 Katarzyna Kolasa PhD, Head of Central & Eastern Europe Market Access, Biogen Idec International GmbH Industry view 16 20 16 40 Ken Redekop PhD, Institute for Medical Technology Assessment (imta), Erasmus University View from Western Europe 16 40 17 15 Discussion 17 15 18 30 SECTION IV. PERSONALIZED MEDICINE SECTION MODERATOR: Dr. Kósa, József, IME Dr. Nagy, László, META 17 15 17 30 Dr. Pogány, Gábor, Hungarian Federation of People with Rare and Congenital Diseases The field of rare diseases as a model of necessary transformations in healthcare 17 30 17 40 Merész, Gergő, Kóbori, László, Mocsari, Diana, Kosóczki, Éva, Hirka, Gábor, Monostory, Katalin, Kaló, Zoltán Syreon Research Centre Semmelweis University, Research Centre for Natural Sciences, Hungarian Academy of Sciences, Toxi-Coop Research Centre for Toxicology, ELTE Faculty of Social Sciences
The health-economics centred analysis of the CYPtest diagnostic treatment applied for the evaluation of individual drug decomposition ability in the course of kidney transplantation 17 40 17 50 Rózsa, Péter, Dr. Boér, Katalin, Dr. Gerencsér, Zsolt, Dr. Horváth, Zsolt, Dr. Nagy, Zoltán, MediConcept Kft., Saint Margaret Hospital; University of Debrecen, Med Gen-Sol Kft. The multi-aspect evaluation of the Oncotype DX diagnostic treatment before making a decision on whether adjuvant chemotherapy shall be used for an early oestrogen receptor positive, Her2 receptor negative, lymphatic gland negative breast cancer 17 50 18 05 Dr. Oberfrank, Ferenc, Prof. Boncz, Imre D.Sc., MOTESZ, University of Pécs, Institute of Experimental Medicine of the Hungarian Academy of Sciences The potential socio-economic impact of personalised medicine on research, medicine and healthcare 18 05 18 30 Discussion 19 30 23 00 Gala dinner Night cruising on the Danube Awarding the META competition awards 20TH JUNE 2013. (THURSDAY) 8 00 8 30 Registration 8 30 9 00 SECTION V. HEALTH ECONOMIC EXPOSURE MODERATOR: Dr. Bodrogi, József, META 8 30 8 45 Prof. Dr. Simon, Tamás, Hungarian League Against Cancer The opportunities of the Hungarian League Against Cancer in the field of drug assessment 8 45 9 00 Dr. Karner, Cecília, University of West Hungary Ideas on healthcare economics 9 00 10 00 SECTION VI. META YOUTH SECTION MODERATOR: Sinkovits, Balázs, META Borsi, András, META 9 00 9 10 Takács, Eszter, Dr. Kövi, Rita, ELTE The opportunities of capacity planning 9 10 9 20 Zsólyom, Adriána, Merész, Gergő, Nagyjánosi, László, Nagyistók, Szilvia, Dessewffy, Zoltán, Nagy, Balázs, Kaló, Zoltán, Vokó, Zoltán ELTE Faculty of Social Sciences, Syreon Research Centre, Novartis Hungária Kft. The external validation of a health-economics model investigating screening, treatment and care related strategies with respect to diabetes 9 20 9 30 Nagy, Zoltán Bence, Ecseki Adrienn, Rózsa Péter, Bécsi Rita, Tóth Ildikó, Dr. Gerencsér Zsolt MediConcept Kft. A comprehensive analysis of the therapeutic solutions used for the treatment of psoriasis financed by the social insurance, for the period of 2007-2011
9 30 9 40 Vincziczki, Áron, Bécsi, Rita, Borsi, András, Kárpáti, Krisztián, Nádudvari, Nóra, Németh, Gergely, Sinkovits, Balázs, Tóth, Emese, IFI-META working group Multi-criteria based decision making in healthcare 9 40 9 50 Páll Nóra, Kováts, Tamás, Pollner, Péter GYEMSZI - National Institute for Quality and Organizational Development in Healthcare and Medicines, ELTE Faculty of Social Sciences An analysis of Hungarian pharmaceutical trade figures with networks 9 50 10 00 Discussion 10 00 11 00 SECTION VII. SUBSIDY POLICY SECTION MODERÁTOR: Dr. Sinkó, Eszter, SE EMK, head of the Management and Health- Economics department of the Professional Association, IME Dr. Inotai, András, META 10 00 10 15 Borsi, András, Dr. Takács, Péter, Dr. Fehér, László, Janssen-Cilag Kft. An analysis of the therapeutic costs and expenses of antipsychotic medications 10 15 10 30 Jeskó, József, Ecseki Adrienn, ELTE Faculty of Social Sciences MediConcept Kft. Crisis and depression - mental illnesses in the mirror of the economic crisis 10 30 10 45 Dr. Bacskai, Miklós, Tóth, Emese, Lang, Zsolt, Healthware Consulting Ltd. Bayes-models in the support of finance related decisions 10 45 11 00 Komáromi, Tamás, Gyáni, Gergely, Andriska, Péter, Healthware Consulting Ltd An imprint of the system of blind bidding 11 00 13 15 SECTION VIII. HEALTH POLICY II AN ANALYSIS OF THE PATIENT JOURNEY MODERÁTOR: Dr. Kövi, Rita, META Dr. Bodrogi, József, META 11 00 11 15 Dr. Nagy, Júlia, Kiss, Zsolt, Fadgyas-Freyler, Petra OEP - National Health Insurance Fund Administration of Hungary Diagnosys of diagnostic care - analyses for the therapy 11 15 11 30 Lang, Zsolt, Bacskai, Miklós, Tóth, Emese, Rakonczai, Pál, Healthware Consulting Ltd. The causal analysis of longitudinal data about patient volume 11 30 11 45 Dr. Kósa, István, Király, Ferenc, Nemes, Attila, Vassányi, István Cardiac Rehabilitation Institute of Hungarian Defence Force, University of Pannonia, University of SZTE The cost effects of the selected patient journey in the case of check-ups based on a suspected coronary heart disease 11 45 12 00 Király, Ferenc, Nemes, Attila, Vassányi, István, Dr. Kósa, István Cardiac Rehabilitation Institute of Hungarian Defence Force, University of Pannonia, University of SZTE Effects of the distance of the invasive service provider in the case of checkups based on a suspected coronary heart disease
12 00 12 15 Kiss, Zsolt, Dr. Nagy, Júlia, Árki, Kornél, OEP- National Health Insurance Fund Administration of Hungary Accessibility, transparency, limited costs - results of the National On-line Waiting List Registration System (SOR-REND) in connection with the developments of healthcare 12 15 12 30 Tóth, Emese, Hegyi, Ramóna, Csiha, Julianna, Lang, Zsolt Healthware Consulting Ltd. Evaluation of efficiency of the oncological patients ways at OEP s providing datas 12 30 13 15 Poster presentation 13 15 14 00 Lunch 14 00 15 30 SECTION IX. OTHER TECHNOLOGIES SECTION MODERATOR: Dr. Tótth, Árpád, META Dr. Jóna, Gabriella, META 14 00 14 15 Dr. Dózsa, Csaba, Krenyácz, Éva, Kósa, Klára, Borcsek, Barbara Med-Econ Kft., University of Budapest, University of Miskolc The health-economics focused approach of hospice-palliative care 14 15 14 30 Dr. Benedek, Zsófia, Krenyácz, Éva, Dr. Dózsa, Csaba Semmelweis University, Bajcsy-Zsilinszky Hospital, Corvinus University of Budapest, Med-Econ Kft. University of Miskolc The Hungarian opprotunities of laparoscopic colorectal surgeries 14 30 14 45 Dr. Kovács, Gábor, Dr. Somogyvári, Zs., Dr. Kósa, József, Dr, Nagyjánosi, László, Dr. Maka, E. Peter Cerny Foundation, IME, Syreon Research Centre, Semmelweis University, Ophthalmology Clinic Cost savings achieved with retinal imaging by the sick-bed (based on a system focusing on the saving of premature babies) and telemetric evaluations in the retinopathy screening of premature babies 14 45 15 00 Ecseki, Adrienn, Rózsa, Péter, Bécsi, Rita, Nagy Z., Bence, Gerencsér, Zsolt MediConcept Kft. An analysis on the efficiency of AVASTIN 15 00 15 15 Gimesi-Országh, Judit, Fadgyas-Freyler, Petra, OEP - National Health Insurance Fund Administration of Hungary Data supply by the National Health Insurance Fund Administration of Hungary - public data represent public property 15 15 15 30 Papp, Eszter, Dr. Juhász, Jácinta, Dr. Jóna, Gabriella, GYEMSZI - National Institute for Quality and Organizational Development in Healthcare and Medicines Molecularly targeted therapies in advanced renal-cell carcinoma Relative efficiency, guidelines, recommendations for finances 15 30 16 30 SECTION X. VACCINATION SECTION 15 30 15 45 Hegyi, Ramóna, Mészáros, Kinga, Tóth, Emese, Dr. Nagy, Bence, Dr. Kaló, Zoltán Healthware Consulting Ltd., GlaxoSmithKline Kft., Syreon Research Centre Publicly financed care of cervical cancer and pre-conditions and other diseases caused by HPV in Hungary
15 45 16 00 Dr. Balogh, Sándor, National Institute of. Primary Care, University of Pécs Medical School, Institute of Family Medicine The healthcare/primary care in crisis? Primer prevention, immunization 16 00 16 15 Mikudina, Boglárka, Erdész, Diána, Mészáros, Kinga, Nagy Z., Bence Healthware Consulting Ltd., MSD Pharma Hungary Kft., GlaxoSmithKline Kft., MediConcept Kft. The financing and efficiency of vaccination programmes based on international examples 16 15 16 30 Discussion 16 30 18 00 SECTION XI. ROUNDTABLE DISCUSSION-DEBATE WHAT DO THE ACTORS OF THE HUNGARIAN VACCINATION MARKET THINK ABOUT THE TOPICAL ISSUES OF VACCINATIONS (IMMUNIZATION)? Moderator: Dr. Kaló, Zoltán, META, IME Planned participants: Dr. Csohán, Ágnes, Hungarian National Centre of Epidemiology Dr. Kulcsár, Andrea, Unified Szent István and Szent László Hospital of the City Council Dr. Kissné, Dr. Horváth Ildikó, Ministry of Human Resources Dr. Ócsai, Lajos Office of the Chief Medical Officer of State 18 00 End of the conference Highlighted sponsors: Further information: LARIX Kiadó Kft. 1089 Budapest, Kálvária tér 3. Tel/Fax.: 210-2682, 333-2434 E-mail: larix@larix.hu, ime@imeonline.hu www.imeonline.hu, www.larix.hu